Aprèsflex®
Originaltext auf Französisch.
In Kanada zugelassenes natürliches Gesundheitsprodukt
Falls dieses Produkt in Frankreich verkauft würde
Nach den von uns angewandten Vorschriften wurde kein Punkt festgestellt.
Eine Tagesmenge wird nur bei ausdrücklicher oraler Dosierung für Erwachsene berechnet, die pro Tag und in einer zur Produktform passenden festen Einheit angegeben ist. Mehrdeutige Einheiten, Flüssigkeiten, Pulver und pädiatrische Dosen werden nicht hochgerechnet. Eine nicht berechnete Menge wird nicht mit Dosisgrenzwerten verglichen. Diese Analyse stellt weder eine Verkaufszulassung in Frankreich noch eine Sicherheits- oder Wirksamkeitsbewertung dar.
Zusammensetzung
Arzneiliche Zusammensetzung nicht angegeben.
Nicht arzneiliche Inhaltsstoffe
Cellulose microcristalline, Hypromellose, Stéarate de magnésium
In Kanada empfohlene Dosen
| Bevölkerungsgruppe | Alter | Menge pro Einnahme | Häufigkeit |
|---|---|---|---|
| Adultes | minimum : 18 ans | 1 Capsule | 2 Tous les jours |
In Kanada zugelassene Verwendungen
Helps to relieve joint pain associated with mild to moderate osteoarthritis of the knee. Helps relieve joint pain and stiffness in persons suffering from mild to moderate osteoarthritis of the knee in as little as 7 days. Supportive therapy for joint pain associated with osteoarthritis of the knee. May help reduce joint pain associated with osteoarthritis of the knee through supporting healthy inflammatory response. Helps to improve joint Function by reducing joint pain in patients with Osteoarthritis of the knee. Supports Joint function and Joint mobility in individuals with osteoarthritis of the knee. Helps to minimize joint discomfort associated with osteoarthritis of the knee. Temporarily relieves joint pain in persons suffering from mild to moderate osteoarthritis of the knee in as little as 5 days. Clinically proven to temporarily provide joint pain relief in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days. Clinically proven to temporarily improve joint stiffness pain in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days. Clinically proven to temporarily improve joint comfort (i.e. Stiffness and pain relief) pain in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days. Clinically proven to temporarily provide joint pain relief pain in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days. Clinically proven to temporarily improve joint function pain in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days. Provides long-term joint health benefits/support/pain relief in subjects suffering from mild to moderate osteoarthritis of the knee. Helps support improvements to joint comfort, stiffness and function over 6 months in persons with mild to moderate osteoarthritis of the knee. Helps to maintain joint space in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to maintain cartilage in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to maintain cartilage thickness/volume in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to protect (knee) cartilage in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to reduce cartilage breakdown in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to reduce key biomarkers of cartilage breakdown in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to improve joint function in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to improve/increase mobility when walking and stair-climbing in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to support joint function capacity when walking and stair-climbing in subjects suffering from mild to moderate osteoarthritis of the knee. Helps to protect against the deterioration of cartilage in persons with mild to moderate osteoarthritis of the knee. A factor in maintaining healthy cartilage and/or joint health in persons with mild to moderate osteoarthritis of the knee. Helps protect against the deterioration of cartilage in persons with mild to moderate osteoarthritis of the knee and relieve joint pain associated with mild to moderate osteoarthritis of the knee. Helps to improve/increase mobility in those suffering from mild to moderate osteoarthritis of the knee. Helps reduce mild to moderate osteoarthritic knee joint pain when walking and climbing stairs. Helps relieve joint pain and stiffness in persons suffering from mild to moderate osteoarthritis of the knee in as few as 5 days.
Originaltext auf Englisch.
Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.
Warnhinweise in Kanada
Cautions and Warnings : Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a healthcare practitioner if symptoms persist or worsen.
Originaltext auf Englisch.
Known Adverse Reactions : Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal effects such as diarrhea, abdominal pain/cramps and nausea.
Originaltext auf Englisch.
Produktdaten
- Andere Namen
- 5-Loxin Advanced®, Aflapin®
- Inhaber
- PLT Health Solutions Inc.
- NPN oder DIN-HM
- 80125104
- Status
- Aktive Lizenz
- Lizenzdatum
- 21. Juni 2023
- Überarbeitungsdatum
- 12. Juli 2024
- Form
- Capsule
- Verabreichungsweg
- Orale
- Art des Antrags
- Générale (non traditionelle)
Quelle
Amtlicher Health-Canada-Eintrag, Zulassung 80125104
Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Originaltext auf Englisch.
Originaltext auf Französisch.
Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.
Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).
Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.